Quoin Pharmaceuticals Ltd...

NASDAQ: QNRX · Real-Time Price · USD
7.33
0.03 (0.34%)
At close: Aug 15, 2025, 12:22 PM

Quoin Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
100.47K 103.44K 103.64K 104.11K
Gross Profit
-100.47K -103.44K -103.64K -104.11K
Operating Income
-9.57M -9.38M -8.41M -20.37M
Interest Income
561.14K 692.82K 95.75K 1.36K
Pretax Income
-8.96B -8.66M -9.38M -21.46M
Net Income
-9.01M -8.69M -9.38M -21.46M
Selling & General & Admin
5.95M 6.07M 6.58M 4.5M
Research & Development
3.52M 3.31M 2.67M 1.56M
Other Expenses
n/a n/a n/a n/a
Operating Expenses
9.47M 9.38M 9.26M 6.06M
Interest Expense
n/a n/a 714.08K 1.09M
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
-9.57M 9.38M 9.26M 6.06M
Income Tax Expense
-8.95B 22.38K n/a n/a
Shares Outstanding (Basic)
133.96K 900.92K 403.88K 26.41K
Shares Outstanding (Diluted)
133.96K 901.1K 403.88K 26.41K
EPS (Basic)
-67.17 -9.64 -22.97 -815.52
EPS (Diluted)
-67.17 -9.64 -22.97 -815.52
EBITDA
-8.9M -9.27M -8.53M -21.37M
EBIT
-9.01M -9.38M -8.63M -21.48M
Depreciation & Amortization
100.47K 103.44K 103.64K 104.11K